2-Propylpentanamide 2-丙基戊酰胺

CAS 2430-27-5 MFCD00051534

化学结构图

2430-27-5
SMILES: CCCC(CCC)C(N)=O

化学属性

Mol. FormulaC8H17NO
Mol. Weight143.23
Melting Point123-125 °C
TSCANo
Boiling Point261.35 °C at 760 mmHg

别名和识别编码

Chemical Name2-Propylpentanamide
CAS Number2430-27-5
MDL NumberMFCD00051534
Synonym Valpromide {LY} Valpromide {} {LY} Valpromide {} {} {LY} Valpromide {} {} {} {LY} Valpromide {} {} {} {} {LY} Valpromide {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {} {} {} {} {} {} { {} {} {} {} {} {} {} {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} { {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} Valpromide {} {} {} {} {} {} {} {} {} {} {} {} {} {} {
EC Number219-394-2
Merck Number14,9914
Beilstein Registry Number1750444
Chemical Name Translation2-丙基戊酰胺
Wiswesser Line NotationZVY3&3
PubChem Substance ID71113
LabNetwork Molecule IDLN01309214
InChIInChI=1S/C8H17NO/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H2,9,10)
Canonical SMILESCCCC(CCC)C(N)=O
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • {SNA} Anticonvulsants, Approved Therapeutics/Drug Candidates, Cell Signaling and Neuroscience, Neurobiology, Neuroscience, Pharmacologicals, Sanofi Aventis, 细胞生物学
  • {SNA} Anticonvulsants, Approved Therapeutics/Drug Candidates, Cell Biology, Cell Signaling and Neuroscience, Neurobiology,

相关文献及参考

  • [2]. Gorres KL, et al. Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus. MBio. 2016 Mar 1;7(2):e00113.
  • [1]. Pacifici GM, et al. Valpromide inhibits human epoxide hydrolase. Br J Clin Pharmacol. 1986 Sep;22(3):269-74.
  • [1]. Pacifici GM, et al. Valpromide inhibits human epoxide hydrolase. Br J Clin Pharmacol. 1986 Sep;22(3):269-74.
  • [2]. Gorres KL, et al. Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus. MBio. 2016 Mar 1;7(2):e00113.

安全信息

RTECSYV5965500
Safety Statements
  • S22 Do not breathe dust 不要吸入粉尘;
  • S36/37 Wear suitable protective clothing and gloves 穿戴适当的防护服和手套;
  • S36 Wear suitable protective clothing 穿戴适当的防护服;
Risk Statements
  • R22 Harmful if swallowed 吞咽有害
GHS Symbol
Hazard statements
  • H302 Harmful if swallowed 吞食有害
WGK Germany3
Signal word Warning
Hazard Codes Xn
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 950 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   85GNAW "Pharmacodynamie de l'Acide Dipropylacetique (ou
   Propyl-2-Pentanoique) et de ses Amides," Carraz, G., Imprimerie Eymond, 1968
    Volume(issue)/page/year: -,71,1968

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 890 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   85GNAW "Pharmacodynamie de l'Acide Dipropylacetique (ou
   Propyl-2-Pentanoique) et de ses Amides," Carraz, G., Imprimerie Eymond, 1968
    Volume(issue)/page/year: -,72,1968

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 438 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   CYLPDN Zhongguo Yaoli Xuebao.  Acta Pharmacologica Sinica.  Chinese Journal
   of Pharmacology.  (China International Book Trading Corp., POB 2820,
   Beijing, Peop. Rep. China)  V.1-    1980-  Volume(issue)/page/year:
   9,37,1988

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 600 mg/kg
SEX/DURATION            : female 8 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
   FAATDF Fundamental and Applied Toxicology.  (Academic Press, Inc., 1 E.
   First St., Duluth, MN 55802) V.1-    1981-  Volume(issue)/page/year:
   6,669,1986

Storage condition 2-8°C {LY} 2-8°C {} {LY} 2-8°C {} {} {LY} 2-8°C {} {} {} {LY} 2-8°C {} {} {} {} {LY} 2-8°C {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {LY} 2-8°C {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} { {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {

其他信息

  • 用途一:抗癫痫药,用于多种类型癫痫的治疗与预防
  • MOL 文件:2430-27-5.mol
  • 丙戊酰胺价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2010/05/25 L08847 2,2-二-正丙基乙酰胺, 97% 2,2-Di-n-propylacetamide, 97% 5g 881元 2010/05/25 L08847 2,2-二-正丙基乙酰胺, 97% 2,2-Di-n-propylacetamide, 97% 25g 3038元
  • Alfa Aesar:2,2-二-正丙基乙酰胺,97% 2,2-Di-n-propylacetamide, 97%(2430-27-5)

系列性分类


相关产品推荐